Marijuana Stocks & Publicly Traded Cannabis Companies

GW Pharma scuttles UK listing to trade on U.S. market

GW Pharmaceuticals, a high-flying biotech firm in the United Kingdom that is seeking U.S. regulatory approval for a CBD-based drug, has abandoned its U.K. stock market listing to instead trade exclusively in the United States. The firm announced it would ditch its Aim market listing this December, according to Britain’s Telegraph newspaper. A company executive […]

Read More

Cannabis REIT files to be listed on NYSE

A cannabis-focused real estate investment trust has filed to list its shares on the New York Stock Exchange. If approved, it would be the first marijuana-related company to list on the Big Board. Innovative Industrial Properties, headquartered in San Diego but incorporated in Maryland, filed documents with the Securities and Exchange Commission on Monday saying it plans to sell […]

Read More

Another Canadian MMJ cultivator plans to go public

Canadian medical cannabis producer Emblem is set to go public next month on the TSX Venture Exchange, the electronic exchange owned by the parent of the Toronto Stock Exchange. The Ontario company is the latest federally licensed medical marijuana cultivator to list its shares on an exchange, thanks to Canada’s legalized MMJ industry. Emblem President […]

Read More

Cultivator Aurora Cannabis raises CA$25 million

Alberta, Canada-based medical marijuana cultivator Aurora Cannabis announced Tuesday that it plans to raise 25 million Canadian dollars ($19 million) in a private placement of convertible debentures. The debt instruments mature in two years and can be converted into shares priced at CA$2. Under the terms of the private placement, Aurora said in a press […]

Read More

MassRoots pays off March debt of nearly $1M

MassRoots, the publicly traded cannabis-centric social media site, said Friday it has repaid its creditors after disclosing last month it had missed nearly $1 million in payments that were due to holders of its convertible notes. “We’re excited to have this debt fully repaid and behind us. We expect MassRoots will be cash-flow positive on […]

Read More

GW Pharma’s latest clinical trial successful, stock soars

British cannabis company GW Pharmaceuticals has conducted a successful clinical trial in which it treated epileptic children with one of its marijuana-based drugs, triggering a surge in the company’s stock price. According to Reuters, tested doses of GW Pharmaceutical’s drug Epidiolex “were found to have induced a statistically significant improvement in reducing seizures” in patients […]

Read More

Medical Marijuana Inc. partners with CannaNative on CBD product

California-based Medical Marijuana Inc. and Native American company CannaNative have put together a hemp-derived CBD product line to be sold on tribal lands. The companies said in a news release Monday that Medical Marijuana Inc. and its HempMeds subsidiary will produce the product line, which will be sold under the CannaNative brand. It will be offered […]

Read More

Canadian MJ companies raise tens of millions in financing

Within the span of a week and a half, a trio of Canadian medical cannabis producers announced they had all raised seven-figure amounts to expand their businesses. First it was Aphria, which revealed on July 28 that it had entered into a “bought deal” that would net it CA$25 million, in exchange for 12.5 million […]

Read More

CO online wholesaler partnering with cannabis software firms

Colorado-based online wholesale platform Cannabase has entered into exclusive partnerships with seed-to-sale tracking software companies MJ Freeway and BioTrackTHC. The partnership, announced by the companies, will bring new weight to Cannabase’s pricing and inventory information, given that it will now be backed by MJ Freeway’s and BioTrackTHC’s data. In a pair of news releases, Cannabase […]

Read More